Schistosoma mansoni venom allergen-like proteins:phylogenetic relationships, stage-specific transcription and tissue localization as predictors of immunological cross-reactivity by Farias, Leonardo P. et al.
Aberystwyth University
Schistosoma mansoni venom allergen-like proteins
Farias, Leonardo P.; Chalmers, Iain W; Perally, Samirah; Rofatto, Henrique K.; Jackson, Colin J.; Brown,
Martha; Khouri, Mariana I.; Barbosa, Mayra M. F.; Hensbergen, Paul J.; Hokke, Cornelis H.; Leite, Luciana C.
C.; Hoffmann, Karl F
Published in:





Citation for published version (APA):
Farias, L. P., Chalmers, I. W., Perally, S., Rofatto, H. K., Jackson, C. J., Brown, M., Khouri, M. I., Barbosa, M. M.
F., Hensbergen, P. J., Hokke, C. H., Leite, L. C. C., & Hoffmann, K. F. (2019). Schistosoma mansoni venom
allergen-like proteins: phylogenetic relationships, stage-specific transcription and tissue localization as predictors





Copyright and moral rights for the publications made accessible in the Aberystwyth Research Portal (the Institutional Repository) are
retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the
legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the Aberystwyth Research Portal for the purpose of private study or
research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the Aberystwyth Research Portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
tel: +44 1970 62 2400
email: is@aber.ac.uk
Download date: 09. Jul. 2020
International Journal for Parasitology 49 (2019) 593–599Contents lists available at ScienceDirect
International Journal for Parasitology
journal homepage: www.elsevier .com/locate / i jparaSuccinctusSchistosoma mansoni venom allergen-like proteins: phylogenetic
relationships, stage-specific transcription and tissue localization as
predictors of immunological cross-reactivityhttps://doi.org/10.1016/j.ijpara.2019.03.003
0020-7519/ 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
⇑ Corresponding author.
E-mail address: krh@aber.ac.uk (K.F. Hoffmann).
1 These authors contributed equally to this work.Leonardo P. Farias a,b,1, Iain W. Chalmers c,1, Samirah Perally c, Henrique K. Rofatto a, Colin J. Jackson c,
Martha Brown c, Mariana I. Khouri b, Mayra M.F. Barbosa a,d, Paul J. Hensbergen e, Cornelis H. Hokke f,
Luciana C.C. Leite a, Karl F. Hoffmann c,⇑
aCentro de Biotecnologia, Instituto Butantan, Av. Vital Brasil, 1500, 05503-900 São Paulo, SP, Brazil
b Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Rua Waldemar Falcão, Salvador, Bahia, Brazil
c Institute of Biological, Environmental and Rural Sciences, Aberystwyth University, SY23 3FG Aberystwyth, UK
d Programa de Pós-Graduação Interunidades em Biotecnologia, Universidade de São Paulo, São Paulo, SP, Brazil
eCenter for Proteomics and Metabolomics, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands
fDepartment of Parasitology, Leiden University Medical Centre, P.O. Box 9600, 2300 RC Leiden, The Netherlands
a r t i c l e i n f oArticle history:
Received 21 December 2018
Received in revised form 25 March 2019
Accepted 28 March 2019





Schistosoma mansonia b s t r a c t
Schistosoma mansoni venom allergen-like proteins (SmVALs) are part of a diverse protein superfamily
partitioned into two groups (group 1 and group 2). Phylogenetic analyses of group 1 SmVALs revealed
that members could be segregated into subclades (A–D); these subclades share similar gene expression
patterns across the parasite lifecycle and immunological cross-reactivity. Furthermore, whole-mount
in situ hybridization demonstrated that the phylogenetically, transcriptionally and immunologically-
related SmVAL4, 10, 18 and 19 (subclade C) were all localized to the pre-acetabular glands of immature
cercariae. Our results suggest that SmVAL group 1 phylogenetic relationships, stage-specific transcrip-
tional profiles and tissue localization are predictive of immunological cross-reactivity.
 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Schistosomiasis, a disease caused by parasitic flatworms within
the genus Schistosoma, affects 200 million people in sub-Saharan
Africa, South America and the Far East, with a further 600 million
at risk of developing the disease (McManus et al., 2018). Currently,
treatment against schistosomiasis relies on a single drug, Prazi-
quantel (PZQ), which may lead to drug resistance and, over the
long term, reduced efficacy (Doenhoff and Pica-Mattoccia, 2006).
Therefore, the search for new sustainable control strategies and
intervention targets remains an important priority.
In light of this objective, discoveries obtained through post-
genomics investigation (Hokke et al., 2007) have led to studies
focused on the identification of novel schistosome antigens puta-
tively involved in the parasite/host interface. As a result, remark-
able progress in the understanding of schistosome secretions and
tegumental composition has been achieved, revealing the presence
of multigenic protein families including the tegument allergen-like
proteins (TALs), Tetraspanins, micro-exon gene (MEGs), Ly6proteins and the venom-allergen like proteins (VALs) (reviewed
in Wilson (2012)). While several members of these families are
being examined for vaccine potential (e.g. Schistosoma mansoni tet-
raspanin 2 (SmTSP2); (Tran et al., 2006) and Sm29; (Cardoso et al.,
2008)), an important aspect that has been overlooked is the extent
to which immunological cross-reactivity occurs with respect to
members of a given protein family.
Cross-reactive immune responses related to a group of proteins
are crucially important in many areas of biology. However, the
majority of research in this area focuses on inter-species/strain
cross-reactivity, as for example the overlap in allergens between
different foods (Kazatsky and Wood, 2016) and overlapping
responses between species/strains of pathogens (Lee and Wilson,
2015; Cao et al., 2016). Nevertheless, there is an increasing under-
standing that immunological cross-reactivity occurring in response
to similar protein family members in the same species can be crit-
ical to provide immunity against parasites. In malaria, a study of
the vaccine candidate merozoite surface protein 3 (MSP3) showed
that six related MSP3 genes presented conserved transcript expres-
sion profiles, similar localization and serological cross-reactivity
(Singh et al., 2009). Limiting/avoiding cross-reactivity is also a
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families such as P. falciparum erythrocyte membrane protein 1
(PfEMP1) (Klein et al., 2014) and Trypanosoma brucei variant sur-
face glycoproteins (VSG), are critical to pathogen survival (Cross,
1977). Importantly, in human schistosomiasis natural immunity
has also been associated with cross-reactive antibody responses
to related SmTAL proteins (Fitzsimmons et al., 2012). Given these
findings, this study proposed to examine antigenic cross-
reactivity within the Schistosoma mansoni VAL protein family, since
a number of these members are present in parasite secretions and
are also being investigated as anti-schistosomal vaccine candidates
(Farias et al., 2011).
All SmVALs contain the SCP/TAPS (Sperm-coating protein/ Tpx-
1/Ag5/PR-1/Sc7; Pfam PF00188) domain, which is a conserved a-b-
a sandwich structure, ubiquitously found in family members
across phyla. To date there have been 29 SCP/TAPS domain-
containing proteins identified in S. mansoni (SmVAL1-28 from
Chalmers et al. (2008) and SmVAL29 from Farias et al. (2012)).
The SmVAL family is divided into two distinct sub-groups. All
SmVALs from group 1 contain a predicted signal sequence and
six highly conserved cysteine residues capable of forming disul-
phide bridges, indicating that these are secreted by the parasite.
Group 2 SmVALs, which are fewer in number, consisting of only
five members, are unlikely to be secreted due to their lack of a sig-
nal sequence as well as the six highly conserved cysteine residues.
This is supported by the detection of multiple group 1 SmVALs in
proteomic studies of parasite excretory/secretory (E/S) products
including cercarial secretions (SmVAL4, 10 and 18; (Curwen
et al., 2006; Hansell et al., 2008)), egg secretions (SmVAL2, 3, 5
and 9; (Cass et al., 2007)), miracidial/sporocyst secretions
(SmVAL2, 3/23, 5/15, 9, 26/28, 27 and 29; (Wu et al., 2009;
Farias et al., 2012)) and egg hatching fluid/secretions
(SmVAL26/28; (Mathieson and Wilson, 2010; Farias et al., 2012)).
Despite the abundance of group 1 SmVALs in these important life
stages, the understanding of SmVAL function remains somewhat
limited. A lipid-binding function was demonstrated for SmVAL4
(Kelleher et al., 2014), a plasminogen-binding function was
revealed for SmVAL18 (Fernandes et al., 2017) and a host matrix
metalloprotease modulatory function detected for SmVAL9
(Yoshino et al., 2014). The group 2 protein SmVAL6 has recently
been shown to be a target for IgE, IgG4 and IgG1 responses in
infected individuals, indicating that the SmVALs may influence
the immune response (Farnell et al., 2015). However, these studies
have limited their focus to individual SmVALs. Here, we demon-
strate that phylogenetic, gene expression and spatial localization
information can be used in combination to predict group 1 SmVAL
immunological cross-reactivity. Further extending this analysis to
the entire SmVAL family (and other multigenic families) may help
assist in the selection of next generation of vaccine candidates.
The S. mansoni life cycle was maintained in hamsters or Tuck
Ordinary (T.O.) mice (Harlan, USA) and experimental protocols
were approved by both the Aberystwyth University (UK) animal
welfare and ethical review body (AWERB, project license PPL
40/3700) and the Institutional Review Board on Animal Experi-
mentation of the Butantan Institute, Brazil (CEUAIB; license no.
604-2009). Schistosoma mansoni cercariae, schistosomula, adult
worms, eggs, miracidia and mother sporocysts (24 h and 96 h
sporocysts) were obtained as previously described (Chalmers
et al., 2008). Germ balls were obtained as previously described
(Fernandes et al., 2017).
To examine whether antigenic cross-reactivity could occur
between the SmVAL protein family members, we first compared
the expression profiles of SmVALs at different stages of the parasite
life cycle with respect to phylogenetic relatedness. Previous quan-
titative reverse transcription PCR (qRT-PCR) analysis provided gene
expression quantification for 16 of the 29 Smval transcripts (1–13,15, 21 and 23) (Chalmers et al., 2008). Herein we attempted to
extend this analysis across the entire SmVAL family (data for
SmVAL24 and 25 are absent due to amplification failures despite
repeated attempts). Parasite materials, RNA extraction and cDNA
synthesis as previously described (Chalmers et al., 2008) were used
in qRT-PCR analyses of Smvals 14, 16–20, 22 and 26–29 (qRT-PCR
primers used can be found in Supplementary Table S1). In the cases
of Smval26, 27 and 28, due to extremely high levels of sequence
similarity (90–99% identity at the nucleotide level), a single com-
bined expression profile representing these three transcripts was
produced. This was also the case in a previous study for Smval1/21,
Smval3/23 and Smval5/15 (Chalmers et al., 2008). Of the nine new
expression profiles obtained, several displayed peak expressions
in stages associated with parasite invasion or establishment in
the mammalian host (e.g. Smval14, 16, 18 and 19), whilst others
appear to be highly expressed in stages related to parasite invasion
of the invertebrate host (e.g. Smvals 20, 22, 26/27/28, and 29). The
only exception was Smval17, which presented elevated expression
in miracidia and cercariae stages (Supplementary Fig. S1).
The SmVAL expression profiles were then compared with
SmVAL phylogenetic relationships to investigate whether closely
related SmVALs (based on primary amino acid sequences) also
shared common transcriptional patterns across the life cycle. To
directly compare SmVAL expression profiles, data were converted
to reflect relative abundance, in which the lifecycle stage with
the highest expression value was designated as score 1.0, while
expression in the other lifecycle stages was normalized accord-
ingly. Expression data for Smval1-13, 15, 21 and 23 was derived
from data originally published by Chalmers et al. (2008). For phy-
logram construction, Bayesian phylogenetic analysis was per-
formed as outlined in Chalmers et al. (2008) using an amino acid
sequence alignment of the 30 SCP/TAPS domains with non-
conserved regions removed. The phylogram showed four well-
supported subclades (A–D) within the group 1 SmVALs (Fig. 1).
An examination of qRT-PCR expression within these subclades
revealed clusters of genes with very similar expression profiles,
which is reflective of high sequence relatedness. For example, in
subclade A, SmVAL5, 9, 15, 26, 27, 28 and 29 group together (pos-
terior probability support value 1.00), all exhibiting high levels of
expression within the miracidia life stage, yet minimal expression
levels in most other life stages (Fig. 1). In subclade C, SmVAL4,
SmVAL10, SmVAL18, SmVAL19 and SmVAL20 all group together
(posterior probability support value 0.72) with all but SmVAL20
sharing a similar expression profile that peaks in the cercaria stage
(Fig. 1). In contrast, subclade B presents a mixed profile, with one
member (SmVAL2) showing peak expression in the miracidia
stage, versus another (SmVAL22) in sporocysts, while others
(SmVAL1 and 21) peak in cercariae and one (SmVAL14) shows ele-
vated expression in the adult stage (Fig. 1). It is interesting to note
that most group 1 proteins exhibit peak expression in the penetrat-
ing larval stages (miracidia and cercariae). The exceptions to this
are SmVAL7, 8 and 12, which did not segregate into a distinct sub-
clade, as well as the subclade B member SmVAL14.
Based on SmVAL sequence relatedness, phylogenetic relation-
ships and expression profiles, we hypothesized that cross-
reactivity would occur within the subclades, but not across differ-
ent SmVAL family subclades. To investigate this, recombinant (r)
SmVAL4 and 9 were produced in Escherichia coli as described in a
previous study (Yoshino et al., 2014) and rSmVAL5 protein was
generated in Pichia pastoris (Supplementary Fig. S2); antisera
against each recombinant protein were raised in mice (Supplemen-
tary Data S1). These anti-sera were then used in western blotting
experiments against recombinant proteins and native extracts to
assess cross-reactivity as previously described (Rofatto et al.,
2012). First, experimental confirmation that rSmVAL4 and
rSmVAL5 were recognized by their respective antisera was
Fig. 1. Schistosoma mansoni Venom allergen-like proteins (SmVAL) subclade divisions and expression profile across the parasite life cycle. Rooted phylogram illustration
detailing the 30 SmVAL SCP/TAPS (Sperm-coating protein/ Tpx-1/Ag5/PR-1/Sc7) domain-containing proteins and distinctive subclades (A–D), accompanied by a heat map
showing transcription levels (subject to data availability) at different stages determined by quantitative reverse transcription (qRT)-PCR analysis. Where highly similar
transcripts could not be analysed separately by qRT-PCR, the data is represented jointly. qRT-PCR results for each Smval were transformed into proportional data, where the
value of the life cycle with the highest expression for that Smval was set at 1 and all other life cycle transcript levels compared with that figure. Red represents any lifecycle
stage between 0.8 and 1 compared with the highest measured transcript abundance, while orange (0.6–0.8), green (0.4–0.6), light blue (0.2–0.4) and dark blue (0–0.2)
represent lower comparative expression levels. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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teins and Western blotting using anti-rSmVAL4 and anti-
rSmVAL5 antisera (Fig. 2). While no cross-reactivity across sub-
clades was detected, as anti-rSmVAL4 only recognized itself and
anti-rSmVAL5 did not recognize rSmVAL4, there was evidence of
cross-reactivity within the same subclade, with anti-rSmVAL5
antisera recognizing the SmVAL9 protein.
We then carried out two-dimensional gel electrophoresis (2-
DE) Western blotting and mass spectrometric analysis to test for
cross-reactivity within the A and C subclades by examining native
SmVALs. Parasite protein extract preparations, electrophoresis,
electroblotting, spot isolation, digestion and LC-MS/MS analysis
are described in detail in Supplementary Data S1. For the subclade
C analysis, proteins from cercariae secretions (0–3 h released prod-
ucts (RP)) were examined via 2-DE and blotted using anti-rSmVAL4
antisera. As predicted, due to the high sequence identity in this
subclade (45–46%, complete protein sequence), anti-rSmVAL4
antisera recognized SmVAL4, SmVAL18 and SmVAL19 in the0–3 h RP fraction (Fig. 3A, B, E and Supplementary Table S2). The
results also showed two regions of cross-reactive signals (spots 2
and 5) that, upon LC-MS/MS analysis, yielded no significant hits
to schistosome proteins (Fig. 3A and B). The predicted and
observed molecular weight for some SmVALs differ significantly,
likely due to protein glycosylation, as already demonstrated for
SmVAL4, 10 and 18 (Jang-Lee et al., 2007; Farias et al., 2012). It
is noteworthy that this is the first proteomics analysis reporting
evidence of SmVAL19 protein detection in cercaria to schistoso-
mula (0–3 h RP) secretions. Additionally, we observed a strong sig-
nal on the western blot (Fig. 3B, labeled as spot 5) in a pH region
that resembles what was characterized as SmVAL10 protein by
Curwen et al. (2006). However, we were unable to identify the
SmVAL10 protein in our mass spectrometry analysis, likely due
to low isoelectric focusing resolution.
To further evaluate cross-reactivity within subclade A, anti-
rSmVAL5 antisera was applied to 2-DE blots of S. mansoni soluble
egg antigen (SEA) preparations. SEA preparation, electrophoresis,
Fig. 2. Anti-SmVAL (Schistosoma mansoni Venom allergen-like proteins) antisera cross-react only with intra-subclade members. Evaluation of cross-reactivity using
recombinant SmVALs 4, 5 and 9 and anti-recombinant (r)SmVAL4 and anti-rSmVAL5 antisera. Recombinant proteins were submitted to western blotting (1.5 lg/lane). Blots
were probed with murine antisera (1:15,000) from animals immunized with rSmVAL4 or rSmVAL5 expressed in Pichia pastoris. Signal was developed using a horseradish
peroxidase (HRP)-conjugated anti-mouse IgG secondary antibody (Sigma no. A4416, 1:10,000) and enhanced chemiluminescence (ECL) prime reagent (GE healthcare no.
RPN2232). Blots were exposed for 1 min and images were captured using a CCD camera (BioSpectrum Multi Imaging Unit, UVP, USA).
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described in detail in Supplementary Data S1. The anti-rSmVAL5
antisera recognized proteins with different levels of sequence iden-
tity, namely SmVAL9 (49%), SmVAL26/28 (62/63%), SmVAL27 (60%)
and SmVAL29 (50%) (Fig. 3C, D, E and Supplementary Table S3). It
should be noted that as SmVAL26 and SmVAL28 share almost iden-
tical primary sequences, neither of the peptides identified were
discriminatory between these two SmVALs. Surprisingly, none of
the proteins detected were identified as SmVAL5, again likely
due to isoelectric focusing resolution or MS detection limitations.
To examine whether the subclade C members identified as
cross-reactive shared the same localization within the parasite,
we employed Whole-Mount In Situ Hybridization (WISH), which
we believe is a stringent technique capable of accurately mapping
spatial gene expression in parasite tissue. Prior to conductingWISH
assays, we first evaluated the specificity of the SmVAL4, 10 and 18
RNA probes against their corresponding cDNAs by modified
reverse northern blotting. Briefly, template cDNAs were generated
via the amplification of previously cloned genes using PCR
(Chalmers et al., 2008). Approximately 50 ng of the PCR products
were run on a 1% agarose gel; after documentation, the gel was
submitted to capillary blotting on Hybond-N+ charged nylon mem-
branes (GE Healthcare, USA), followed by depurination, denatura-
tion and neutralization, all carried out according to the
manufacturer’s recommendations. Blocking, probe hybridization
and washing steps, as well as detection techniques, were per-
formed under the same conditions described below for the WISH
assays. Images were captured using an Image Quant LAS 4000
photodocumentation system (GE Healthcare, USA). Our analysis
revealed that, contrary to our results regarding the anti-rSmVAL4
antibody, the SmVAL RNA probes specifically detected their related
cDNAs, with no evidence of cross-reactivity observed (Supplemen-
tary Fig. S3).Next, WISH was used to determine the localization of Smval4, 10
18 and 19 transcripts in immature cercariae. Additionally, Smval1
localization (a subclade B protein expressed in the cercaria) was
examined to ascertain whether different subclades possessed
unique localizations within the parasite. The protocols used for fix-
ation, permeabilization, in situ hybridization and staining of germ
balls and immature cercariae were based on protocols previously
described (Fernandes et al., 2017), and recently used to localize
Smval4 and 24 in the pre-acetabular glands of immature cercariae.
Specific antisense RNA probes were synthesized with digoxigenin
(DIG) in vitro using T7 or Sp6 RNA polymerase (Promega, Madison,
USA) from cDNA sequences previously cloned in a pGEM-T easy
vector (Supplementary Table S1). A Smval4DIG-labeled sense probe
was used as a negative control. All five probes presented clear evi-
dence of staining in the cercaria stage, represented by a band across
the middle of the body along the anterior and lateral edges of the
pre-acetabular glands (Fig. 4A–E). Confocal microscopy employing
Alexa Fluor 647-conjugated lectin (PNA) and FITC-phalloidin was
used to provide additional interpretation of the positioning of
pre- and post-acetabular glands with musculature counterstaining
(Fig. 4G and H), which revealed that two pairs of pre-acetabular
glands lie anterior to the acetabulum, while three pairs of post-
acetabular glands were located posterior to it. In addition, detect-
able levels of these transcripts were observed in other development
stages of germ balls (Supplementary Fig. S4); in some of these, it
was possible to view the two pairs of pre-acetabular glands as indi-
cated by four blue spots (Supplementary Fig. S4C, G, H and L).
Recently, transcriptomic, microarray and proteomic studies
have demonstrated the potential of SmVALs as prospective targets
for immune intervention (reviewed in Chalmers and Hoffmann
(2012)). The present study attempted to extend previous analyses
of the transcriptional expression profiles of the SmVAL family
(Smval14-29, with the exception of Smval15, 21, 23 and 24/25).
Fig. 3. Intra-clade cross-reactivity of anti-rSmVAL4 (recombinant Schistosoma mansoni Venom allergen-like 4 protein) and anti-rSmVAL5 antisera against native SmVALs. (A)
two-dimensional gel electrophoresis (2-DE) of 0–3 h cercarial/schistosomula released products (50 mg) stained with colloidal Coomassie. (B) Western blot of a replica gel
presented in (A) revealing protein spots that cross-react with anti-rSmVAL4 antibodies. (C) 2-DE of soluble egg antigens (SEA) (56 mg) stained with colloidal Coomassie. (D)
Western blot from a replica gel presented in (C) showing spots that cross-react with anti-rSmVAL5 antisera. Positions of molecular mass standards (kDa) are indicated on the
sides of the gels. (E) Spots submitted to LC-MS/MS analysis and SmVAL protein identification. The predicted MW and average pI for each SmVAL identified as defined by
Expasy (https://web.expasy.org/compute_pi/) and the number of unique peptides identified during mass spectrometry analysis are displayed. The full mass spectrometric
analysis for all protein identities is detailed in Supplementary Tables S2 and S3.
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ated with invasion or establishment in the mammalian host from
others that appeared to be highly expressed in parasite stages
related to the invasion of the invertebrate host.In order to select an appropriate vaccine candidate in the con-
text of a multi-gene family, it is crucial to consider cross-
reactivity among members. Ultimately, cross-reactivity will deter-
mine the extent by which different antigens are recognized by the
Fig. 4. Localization of Schistosoma mansoni Venom allergen-like protein (SmVAL) transcripts to the pre-acetabular glands in S. mansoni cercariae. Whole mount in situ
hybridization for Smval1, 4, 10 18 and 19 transcripts in immature cercariae. (A–E) focal expression associated with the pre-acetabular glands of immature cercariae hybridized
with Smval1, 4, 10, 18 and 19 probes, respectively. (F) Negative control hybridized with a sense probe of SmVAL4. (G and H) A phalloidin-FITC stained parasite incubated with
PNA-647 in the same orientation to aid interpretation. Note the acetabulum (Ac) and the two and three pairs of pre- and post-acetabular glands, respectively. Scale
bars = 50 mm.
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design. In the case of the schistosome, immunization with antigens
sharing epitopes (i.e. cross-reacting) with egg antigens presents a
potential risk, since this may sensitize to egg proteins, thereby
inducing an immune response against disintegrating eggs that
could consequently exacerbate the pathological process. We have
previously demonstrated the absence of antibody cross-reactivity
between anti-rSmVAL6 (a group 2 protein) and recombinants
SmVAL4, 7 and 26 (all group 1 proteins), which crucially have
low sequence similarity to SmVAL6 (Rofatto et al., 2012). Data pre-
sented here extends these findings, indicating the absence of cross-
reactivity among different subclades of the group 1 SmVALs, while
demonstrating cross-reactivity within these subclades, such as in
subclade C (between SmVAL4, 18 and 19) and in subclade A
(between SmVAL5, 9, 26/28, 27 and 29). Moreover, the detection
of SmVAL19 in cercaria secretions further expands the repertoire
of SmVALs that are likely involved in host invasion.
Within clade cross-reactivity may not occur at low sequence
identity levels though, as previous experiments using anti-
rSmVAL4 failed to detect a cross-reactive protein (such as the clade
C protein SmVAL20) in egg or miracidia extracts using 1D Western
Blot experiments (Farias et al., 2012). In addition, due to the use of
recombinant proteins to raise the anti-sera for these experiments,
we cannot exclude the possibility that additional/different cross-
reactivity could be detected using proteins with native folding
and post-translational modifications. Therefore, a complete under-
standing of schistosome protein cross-reactivity may only be
achieved with the use of anti-sera raised against native proteins
due to schistosome-specific glycosylation such as was detected
for SmVAL9 (Yoshino et al., 2014).Our results demonstrate that anti-SmVAL antibodies cross-react
with members from the same phylogenetic subclade (i.e. those
sharing at least 30% sequence identity), suggesting that cellular
localization studies using these anti-SmVALs antibodies could lead
to misinterpretations. To circumvent this limitation, we employed
the WISH technique, which is more stringent than immunohisto-
chemistry due to the high probe hybridization temperatures used
(60–65 C). The WISH assays determined the tissue localization
of Smval1, 4, 10, 18 and 19 transcripts in the pre-acetabular glands
of stubby-tailed, young elongating-tail and immature cercariae.
These data corroborate and extend previous DNA microarray and
proteomics data (Curwen et al., 2006; Chalmers et al., 2008;
Hansell et al., 2008; Parker-Manuel et al., 2011), which imply that
these SmVAL proteins may play a role in the early stages of infec-
tion. In light of the identification of SjVAL1 in the head gland of cer-
cariae (Chen et al., 2010), it is tempting to speculate that some S.
mansoni orthologs could also be localized in this structure. Our
data, however, exclude this possibility, at least for SmVAL1, 4, 10,
18 and 19. In addition, SjVAL1 localization data was obtained using
polyclonal antibodies, and as demonstrated here, multi-gene fam-
ily immunolocalization data should be interpreted carefully due to
cross-reactivity issues.
The detection of SmVAL1, 4, 10, 18 and 19 provided here,
SmVAL4 and 24/25 described by Fernandes et al. (2017) and,
potentially, SmVAL21, 22 (Parker-Manuel et al., 2011), in the
acetabular glands indicates that 37.5% of all group 1 SmVAL pro-
teins are expressed in this tissue. Although the amount of SmVAL4,
10 and 18 based on spot volume (3%) does not rival the five cer-
carial elastases (34.4% of the total spot volume) (Wilson, 2012),
the large number of group 1 SmVALs (nine) potentially expressed
L.P. Farias et al. / International Journal for Parasitology 49 (2019) 593–599 599in the acetabular glands calls attention to this location as a hotspot
for this gene family. In conclusion, our results highlight the impor-
tance of establishing localization status, as well as determining the
extent of cross-reactivity across the SmVAL family members in
order to better define their vaccine potential.
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